Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis

J Am Acad Dermatol. 2024 Jul;91(1):151-153. doi: 10.1016/j.jaad.2024.03.013. Epub 2024 Mar 19.
No abstract available

Keywords: bladder cancer; epidemiology end results (SEER); lung cancer; melanoma; primary cutaneous B-cell lymphoma (PCBCL); prostate cancer; renal cancer; second primary malignancy (SPM); surveillance; thyroid cancer.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Incidence
  • Kidney Neoplasms / diagnosis
  • Kidney Neoplasms / epidemiology
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / epidemiology
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / epidemiology
  • Male
  • Melanoma* / diagnosis
  • Melanoma* / epidemiology
  • Middle Aged
  • Neoplasms, Second Primary / diagnosis
  • Neoplasms, Second Primary / epidemiology
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / epidemiology
  • SEER Program* / statistics & numerical data
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / epidemiology
  • Skin Neoplasms* / pathology
  • Thyroid Neoplasms* / diagnosis
  • Thyroid Neoplasms* / epidemiology
  • United States / epidemiology
  • Urinary Bladder Neoplasms* / diagnosis
  • Urinary Bladder Neoplasms* / epidemiology